VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb 3, 2016) - Pyng Medical Corp. (TSX VENTURE:PYT), an award-winning developer of trauma and resuscitation products for emergency, combat and critical care ...
September 7, 2010 — The US Food and Drug Administration (FDA) has granted 510(k) clearance for a next-generation sternal intraosseous infusion system (FASTx; Pyng Medical Corp). The device is ...
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Intraosseous Infusion Devices Market Size, Share & Trends Analysis Report By Type (Manual IO Needles, Battery Powered Driver), By End-use (Hospitals and ...
Dublin, April 15, 2022 (GLOBE NEWSWIRE) -- The "Intraosseous Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts ...
The global industry for intraosseous infusion devices is poised for substantial growth, with an estimated value of USD 5,065.8 million in 2025. The market is expected to reach USD 10,463.8 million by ...
The global intraosseous infusion devices market is on a strong growth trajectory, with projections indicating a significant rise from USD 5,065.8 million in 2025 to USD 10,463.8 million by 2035. This ...
VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 02/03/16 -- Pyng Medical Corp. (TSX VENTURE: PYT), an award-winning developer of trauma and resuscitation products for emergency, combat and critical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback